However, published data allows a directional comparison of the most common GI events: Adverse Event Retatrutide (12 mg) Semaglutide 2.4 mg (STEP trials) Tirzepatide 15 mg (SURMOUNT trials) Nausea ~46% ~44% ~31% Diarrhea ~33% ~30% ~23% Vomiting ~22% ~24% ~12% Constipation ~17% ~24% ~12% Important caveat: These numbers come from different trial populations and cannot be directly compared
Overexpression of a pepper basic pathogenesis-related protein 1 gene in tobacco plants enhances resistance to heavy metal and pathogen stresses
In 500 mg or 1 g forms, it neutralizes oxidative
Cambra I, Martinez M, Dder B, GonzlezMelendi P, Gandullo J, Santamara ME, Diaz I (2012) A cathepsin F like peptidase involved in barley grain protein mobilization, HvPap1, is modulated by its own propeptide and by cystatins
Format Separate vials only